"/> Novus Biologicals™ Peptide bloquant d’anticorps SL… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps SLC39A1

Réf. : BL-RE-047137Réf. fabricant : 18278695 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
27173
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76498. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the amino terminus of human ZIP1.

Points forts

Source

Synthetic

(Accession #: NP_055252) The SLC39A1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-047137
Réf. fabricant18278695
Gene ID (Entrez)27173
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76498. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneCGI-08, CGI-71, IRT1, solute carrier family 39 (zinc transporter), member 1, solute carrier family 39 (zinc transporter), member 3, ZIP1, ZIP-1
Symbole de gène(s)SLC39A1
Type de produitSLC39A1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the amino terminus of human ZIP1
Une question, une configuration particulière ?
Contactez-nous pour un devis.